Design, Synthesis, and Biological Evaluation of Some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide Hybrids as MTDLs for Alzheimer’s Disease Therapy
Article in European Journal of Medicinal Chemistry (April 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in European Journal of Medicinal Chemistry (April 2024)
Article in Neural Regeneration Research (January 2024)
Article in Health Sciences Review (June 2023)